Market Overview:
The global cell freezing media for cell therapy market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for stem cell therapies and rising number of clinical trials for stem cells therapies. Based on type, the global cell freezing media for cell therapy market can be segmented into with FBS and without FBS. With FBS segment is expected to account for a larger share in terms of revenue in 2018 as compared to without FBS segment. However, with FBS segment is projected to register a higher CAGR during the forecast period from 2018-2030 owing its advantages over without FBS such as better viability and survival rates of cells post-thawing, less contamination risk, etc.
Product Definition:
Cell freezing media is a type of solution that is used to help preserve cells. It can be used for both therapeutic and research purposes. The importance of cell freezing media for cell therapy is that it helps to keep the cells in a healthy state, which can improve the overall outcome of the treatment.
With FBS:
With FBS, it's usage and growth factor in the Cell Freezing Media for Cell Therapy market is expected to witness significant growth over the forecast period. With FBS, also known as serum-free normal human plasma, it's a vital protein that helps cells to repair and grow properly.
Without FBS:
The global without FBS market is expected to witness significant growth over the forecast period. The primary factor attributing to its lucrative growth is increasing R&D investment in cell therapies and regenerative medicine.
In addition, growing demand for advanced bioreactors and cryopreservation techniques are also anticipated to boost the market during the forecast period.
Application Insights:
The human embryonic stem cells segment dominated the market in terms of revenue share in 2017. The high adoption of these products for regenerative medicine and increasing government support are factors contributing to the growth of this segment. For instance, according to a study published by Nanfang Hospital of Southern Medical University, Guangzhou, China; HESC-based therapy has great potential as an alternative for autologous bone marrow transplantation and may become applicable in clinical practice (Nan Stem Cells January 2018).
Cellular therapies including T cell based therapies such as TILs/TLSs have gained significant traction due to their ability to treat cancer and other immune system disorders. However, because these products are derived from donors they carry a risk of infectious diseases transmission that can be reduced with proper containment techniques such as bio-containment systems used during processing & handling along with quality control measures during production & testing phases (Kryton Biocontainment Systems).
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in research activities and an increase in funding for stem cell therapy. Moreover, an increase in the incidence of cancer is also expected to boost demand for cell freezers used for frozen sectioning. The U.S.
In August 2018, researchers from Japan reported that they had developed a new method called “microwave-assisted thawing†(MA TI) that enables efficient recovery and expansion of human embryonic stem cells (hESC) using only minimal additives or growth factors as supplements.
Growth Factors:
- Increasing demand for cell-based therapies for various diseases
- Growing number of stem cell and regenerative medicine centers
- Rising public and private investments in cell therapy research
- Advances in cryopreservation technologies
- Proliferation of personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Freezing Media for Cell Therapy Market Research Report
By Type
With FBS, Without FBS
By Application
Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others
By Companies
BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Cell Freezing Media for Cell Therapy Market Report Segments:
The global Cell Freezing Media for Cell Therapy market is segmented on the basis of:
Types
With FBS, Without FBS
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioLife Solutions
- Thermo Fisher Scientific
- Merck
- GE Healthcare
- Zenoaq
Highlights of The Cell Freezing Media for Cell Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With FBS
- Without FBS
- By Application:
- Human Embryonic Stem Cells
- CAR-T Cell Therapy
- Neural Stem Cell Therapy
- Mesenchymal Stem Cell Therapy
- Hematopoietic Stem Cell Transplantation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Freezing Media for Cell Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell freezing media is a type of cryopreservation medium that helps preserve cells for future use in medical treatments.
Some of the key players operating in the cell freezing media for cell therapy market are BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq.
The cell freezing media for cell therapy market is expected to grow at a compound annual growth rate of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Freezing Media for Cell Therapy Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cell Freezing Media for Cell Therapy Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cell Freezing Media for Cell Therapy Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cell Freezing Media for Cell Therapy Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cell Freezing Media for Cell Therapy Market Size & Forecast, 2020-2028 4.5.1 Cell Freezing Media for Cell Therapy Market Size and Y-o-Y Growth 4.5.2 Cell Freezing Media for Cell Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 With FBS
5.2.2 Without FBS
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human Embryonic Stem Cells
6.2.2 CAR-T Cell Therapy
6.2.3 Neural Stem Cell Therapy
6.2.4 Mesenchymal Stem Cell Therapy
6.2.5 Hematopoietic Stem Cell Transplantation
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Freezing Media for Cell Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Freezing Media for Cell Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 With FBS
9.6.2 Without FBS
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human Embryonic Stem Cells
9.10.2 CAR-T Cell Therapy
9.10.3 Neural Stem Cell Therapy
9.10.4 Mesenchymal Stem Cell Therapy
9.10.5 Hematopoietic Stem Cell Transplantation
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 With FBS
10.6.2 Without FBS
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human Embryonic Stem Cells
10.10.2 CAR-T Cell Therapy
10.10.3 Neural Stem Cell Therapy
10.10.4 Mesenchymal Stem Cell Therapy
10.10.5 Hematopoietic Stem Cell Transplantation
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 With FBS
11.6.2 Without FBS
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human Embryonic Stem Cells
11.10.2 CAR-T Cell Therapy
11.10.3 Neural Stem Cell Therapy
11.10.4 Mesenchymal Stem Cell Therapy
11.10.5 Hematopoietic Stem Cell Transplantation
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 With FBS
12.6.2 Without FBS
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human Embryonic Stem Cells
12.10.2 CAR-T Cell Therapy
12.10.3 Neural Stem Cell Therapy
12.10.4 Mesenchymal Stem Cell Therapy
12.10.5 Hematopoietic Stem Cell Transplantation
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 With FBS
13.6.2 Without FBS
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human Embryonic Stem Cells
13.10.2 CAR-T Cell Therapy
13.10.3 Neural Stem Cell Therapy
13.10.4 Mesenchymal Stem Cell Therapy
13.10.5 Hematopoietic Stem Cell Transplantation
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Freezing Media for Cell Therapy Market: Competitive Dashboard
14.2 Global Cell Freezing Media for Cell Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioLife Solutions
14.3.2 Thermo Fisher Scientific
14.3.3 Merck
14.3.4 GE Healthcare
14.3.5 Zenoaq